期刊
HEALTH ECONOMICS
卷 25, 期 8, 页码 933-938出版社
WILEY
DOI: 10.1002/hec.3366
关键词
health technology assessment; economic analysis; cost effectiveness analysis; costing; unrelated future costs
资金
- International Public Policy Institute of the University of Strathclyde
- Economic and Social Research Council [1511017] Funding Source: researchfish
In this editorial, we consider the vexing issue of unrelated future costs' (for example, the costs of caring for people with dementia or kidney failure after preventing their deaths from a heart attack). The National Institute of Health and Care Excellence (NICE) guidance is not to take such costs into account in technology appraisals. However, standard appraisal practice involves modelling the benefits of those unrelated technologies. We argue that there is a sound principled reason for including both the costs and benefits of unrelated care. Changing this practice would have material consequences for decisions about reimbursing particular technologies, and we urge future research to understand this better. Copyright (c) 2016 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据